Literature DB >> 17241774

Cell cycle machinery and stroke.

J Rashidian1, G O Iyirhiaro, D S Park.   

Abstract

Stroke results from a transient or permanent reduction in blood flow to the brain. The mechanisms involving neuronal death following ischemic insult are complex and not fully understood. One signal which may control ischemic neuronal death is the inappropriate activation of cell cycle regulators including cyclins, cyclin dependent kinases (CDKs) and endogenous cyclin dependent kinase inhibitors (CDKIs). In dividing cells, activation of cell cycle machinery induces cell proliferation. In the context of terminally differentiated-neurons, however, aberrant activation of these elements triggers neuronal death. Indeed, there are several lines of correlative and functional evidence supporting this "cell cycle/neuronal death hypothesis". The objective of this review is to summarize the findings implicating cell cycle machinery in ischemic neuronal death from in vitro and in vivo studies. Importantly, determining and blocking the signaling pathway(s) by which these molecules act to mediate ischemic neuronal death, in conjunction with other targets may provide a viable therapeutic strategy for stroke damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17241774     DOI: 10.1016/j.bbadis.2006.11.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  44 in total

1.  Assessment of protein expression levels after transient global cerebral ischemia using an antibody microarray analysis.

Authors:  Maria Irene Ayuso; Lidia García-Bonilla; Maria Elena Martín; Matilde Salinas
Journal:  Neurochem Res       Date:  2010-05-11       Impact factor: 3.996

Review 2.  Role of cell cycle re-entry in neurons: a common apoptotic mechanism of neuronal cell death.

Authors:  Jaume Folch; Felix Junyent; Ester Verdaguer; Carme Auladell; Javier G Pizarro; Carlos Beas-Zarate; Mercè Pallàs; Antoni Camins
Journal:  Neurotox Res       Date:  2011-10-01       Impact factor: 3.911

3.  Sertad1 plays an essential role in developmental and pathological neuron death.

Authors:  Subhas C Biswas; Yi Zhang; Grace Iyirhiaro; Ryan T Willett; Yasmilde Rodriguez Gonzalez; Sean P Cregan; Ruth S Slack; David S Park; Lloyd A Greene
Journal:  J Neurosci       Date:  2010-03-17       Impact factor: 6.167

4.  The pro-death role of Cited2 in stroke is regulated by E2F1/4 transcription factors.

Authors:  Tianwen Huang; Yasmilde Rodríguez González; Dianbo Qu; En Huang; Farzaneh Safarpour; Eugene Wang; Alvin Joselin; Doo Soon Im; Steve M Callaghan; Wassamon Boonying; Lisa Julian; Sally L Dunwoodie; Ruth S Slack; David S Park
Journal:  J Biol Chem       Date:  2019-04-09       Impact factor: 5.157

5.  Cell cycle activation and CNS injury.

Authors:  Bogdan A Stoica; Kimberly R Byrnes; Alan I Faden
Journal:  Neurotox Res       Date:  2009-04-21       Impact factor: 3.911

Review 6.  Cell cycle activation and spinal cord injury.

Authors:  Junfang Wu; Bogdan A Stoica; Alan I Faden
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

7.  Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle and cell death in neurons.

Authors:  Sung-Wuk Jang; Xia Liu; Haian Fu; Howard Rees; Manuel Yepes; Allan Levey; Keqiang Ye
Journal:  J Biol Chem       Date:  2009-07-10       Impact factor: 5.157

8.  Sustained (S)-roscovitine delivery promotes neuroprotection associated with functional recovery and decrease in brain edema in a randomized blind focal cerebral ischemia study.

Authors:  Estelle Rousselet; Anne Létondor; Bénédicte Menn; Yann Courbebaisse; Marie-Lise Quillé; Serge Timsit
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-01       Impact factor: 6.200

9.  Cdk5 phosphorylates Cdh1 and modulates cyclin B1 stability in excitotoxicity.

Authors:  Carolina Maestre; Maria Delgado-Esteban; Jose C Gomez-Sanchez; Juan P Bolaños; Angeles Almeida
Journal:  EMBO J       Date:  2008-09-25       Impact factor: 11.598

10.  Delayed treatment with systemic (S)-roscovitine provides neuroprotection and inhibits in vivo CDK5 activity increase in animal stroke models.

Authors:  Bénédicte Menn; Stéphane Bach; Teri L Blevins; Mark Campbell; Laurent Meijer; Serge Timsit
Journal:  PLoS One       Date:  2010-08-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.